Your browser doesn't support javascript.
loading
Gastrointestinal cancer classification and prognostication from histology using deep learning: Systematic review.
Kuntz, Sara; Krieghoff-Henning, Eva; Kather, Jakob N; Jutzi, Tanja; Höhn, Julia; Kiehl, Lennard; Hekler, Achim; Alwers, Elizabeth; von Kalle, Christof; Fröhling, Stefan; Utikal, Jochen S; Brenner, Hermann; Hoffmeister, Michael; Brinker, Titus J.
Affiliation
  • Kuntz S; Digital Biomarkers for Oncology Group, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Krieghoff-Henning E; Digital Biomarkers for Oncology Group, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Kather JN; Department of Medicine III, University Hospital RWTH Aachen, Aachen, Germany.
  • Jutzi T; Digital Biomarkers for Oncology Group, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Höhn J; Digital Biomarkers for Oncology Group, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Kiehl L; Digital Biomarkers for Oncology Group, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Hekler A; Digital Biomarkers for Oncology Group, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Alwers E; Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • von Kalle C; Department of Clinical-Translational Sciences, Charité University Medicine and Berlin Institute of Health (BIH), Berlin, Germany.
  • Fröhling S; Department of Translational Medical Oncology, National Center for Tumor Diseases (NCT), German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Utikal JS; Department of Dermatology, Heidelberg University, Mannheim, Germany; Skin Cancer Unit, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Brenner H; Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany; Division of Preventive Oncology, German Cancer Research Center (DKFZ), National Center for Tumor Diseases (NCT), Heidelberg, Germany; German Cancer Consortium (DKTK), German Cancer Resear
  • Hoffmeister M; Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Brinker TJ; Digital Biomarkers for Oncology Group, German Cancer Research Center (DKFZ), Heidelberg, Germany. Electronic address: titus.brinker@dkfz.de.
Eur J Cancer ; 155: 200-215, 2021 09.
Article de En | MEDLINE | ID: mdl-34391053
ABSTRACT

BACKGROUND:

Gastrointestinal cancers account for approximately 20% of all cancer diagnoses and are responsible for 22.5% of cancer deaths worldwide. Artificial intelligence-based diagnostic support systems, in particular convolutional neural network (CNN)-based image analysis tools, have shown great potential in medical computer vision. In this systematic review, we summarise recent studies reporting CNN-based approaches for digital biomarkers for characterization and prognostication of gastrointestinal cancer pathology.

METHODS:

Pubmed and Medline were screened for peer-reviewed papers dealing with CNN-based gastrointestinal cancer analyses from histological slides, published between 2015 and 2020.Seven hundred and ninety titles and abstracts were screened, and 58 full-text articles were assessed for eligibility.

RESULTS:

Sixteen publications fulfilled our inclusion criteria dealing with tumor or precursor lesion characterization or prognostic and predictive biomarkers 14 studies on colorectal or rectal cancer, three studies on gastric cancer and none on esophageal cancer. These studies were categorised according to their end-points polyp characterization, tumor characterization and patient outcome. Regarding the translation into clinical practice, we identified several studies demonstrating generalization of the classifier with external tests and comparisons with pathologists, but none presenting clinical implementation.

CONCLUSIONS:

Results of recent studies on CNN-based image analysis in gastrointestinal cancer pathology are promising, but studies were conducted in observational and retrospective settings. Large-scale trials are needed to assess performance and predict clinical usefulness. Furthermore, large-scale trials are required for approval of CNN-based prediction models as medical devices.
Sujet(s)
Mots clés

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Apprentissage profond / Tumeurs gastro-intestinales Type d'étude: Prognostic_studies / Systematic_reviews Limites: Humans Langue: En Journal: Eur J Cancer Année: 2021 Type de document: Article Pays d'affiliation: Allemagne

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Apprentissage profond / Tumeurs gastro-intestinales Type d'étude: Prognostic_studies / Systematic_reviews Limites: Humans Langue: En Journal: Eur J Cancer Année: 2021 Type de document: Article Pays d'affiliation: Allemagne